We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Highlights.
- Abstract
The article discusses research being done related to clinical pharmacology. One study by Lefebvre et al. assessed cenicriviroc, a CCR5/CCR2 antagonist, in patients with hepatic impairment, in a 2016 issue of "Clinical and Translational Science." Another study by Zanos et al. explored ketamine metabolites for depression treatment, in a 2006 issue of "Nature." A study by Townsley et al. examined the treatment of telomere disease with danazol, in a 2016 issue of "New England Journal of Medicine."
- Subjects
CHEMOKINE receptors; HEPATIC artery; KETAMINE; THERAPEUTICS; MENTAL depression; DANAZOL; DISEASES
- Publication
Clinical Pharmacology & Therapeutics, 2016, Vol 100, Issue 3, p204
- ISSN
0009-9236
- Publication type
Article
- DOI
10.1002/cpt.414